Vaughan Gething AM

Cabinet Secretary for Health and Social Services.

Vaughan was born in Zambia and brought up in Dorset. He was educated at Aberystwyth and Cardiff universities and is married to Michelle. Vaughan is a largely retired cricketer and a fan of both rugby and football.

Vaughan was a solicitor and former partner at Thompsons. He is a member of the GMB, UNISON and Unite unions, and was the youngest ever President of the TUC in Wales. He has previously served as a county councillor and school governor. He has also been a community service volunteer – supporting and caring for a student with cerebral palsy and is former president of NUS Wales.

Between 1999 and 2001, Vaughan worked as a researcher to former AMs Val Feld and Lorraine Barrett. Between 2001 and 2003, Vaughan was the chair of Right to Vote – a cross-party project to encourage greater participation from black minority ethnic communities in Welsh public life.

Vaughan is a member of the Co-operative Party.

In June 2013 Vaughan Gething was appointed Deputy Minister for Tackling Poverty.  In September 2014, Vaughan was appointed Deputy Minister for Health. In May 2016 he was appointed Cabinet Secretary for Health, Well-being and Sport. Vaughan was appointed Cabinet Secretary for Health and Social Services on 3 November 2017.

Ken Skates AM

Cabinet Secretary for Economy and Transport

Ken Skates was born in 1976 in Wrexham, educated at Mold Alun School and went on to study Social and Political Science at Cambridge University.

In his free time, Ken enjoys running, swimming, hiking and golf as well as having an interest in gardening, art and architecture. Ken was previously a journalist and assistant to Mark Tami MP.

In 2008, he was elected a community councillor. Ken’s policy interests include manufacturing, mental health, sport and leisure, eliminating poverty and political economy.  His political interests include skills training, tourism, environmental protection, mental health, sport and fitness and social inclusion.

In June 2013 Ken Skates was appointed Deputy Minister for Skills and Technology. In September 2014, Ken was appointed Deputy Minister for Culture, Sport and Tourism. In May 2016 he was appointed Cabinet Secretary for Economy and Infrastructure.

Ken was appointed Cabinet Secretary for Economy and Transport on 3 November 2017.

Dr. Andrew Goodall

NHS Wales  Chief Executive

Dr Andrew Goodall was appointed to the role of Director General of Health and Social Services/Chief Executive NHS Wales in June 2014. His role includes both supporting Ministerial priorities for health and social care within the Civil Service structures, and the leadership and oversight of NHS Wales.

Including this current role, Andrew has been an NHS Chief Executive in Wales for 12 years, the most recent post being that of Chief Executive of Aneurin Bevan University Health Board, a position held since the Health Board’s inception in October 2009 until 2014.

During his 25 year NHS career, Andrew has held planning and operational positions across a number of NHS organisations across South Wales as well as national roles.  He has particular areas of interest in improving patient safety, quality and patient experience; partnership working across Public Services; and delivering frontline services through service improvement and modernisation.

Dr Goodall has a law degree from Essex University and a PhD in Health Service Management from Cardiff Business School. 

Professor Sir Mansel Aylward
Conducting innovation, accelerating adoption and creating transformational partnerships: How Life Sciences Hub Wales will work with industry and the NHS to achieve mutual success.

Professor Sir Mansel Aylward CB MD DSc FFOM FFPM FRCP FLSW Chair, Life Sciences Hub Wales

Sir Mansel is Chair of Life Sciences Hub Wales.  He is also Chair of the Bevan Commission, an independent expert panel to oversee NHS reforms in Wales and to provide expert advice to the Cabinet Secretary for Health, Sport and Wellbeing. He is professor of Public Health Education at the Centre for Psychosocial and Disability Research at Cardiff University. He was recently appointed as professor of Prudent Health and Wellbeing at the School of Management, Swansea University.

He was the first Chair of Public Health Wales NHS Trust, responsible for the delivery of public health services at national, local and community levels in Wales.  Earlier in his career he was Chief Medical Officer, Medical Director and Chief Scientist at the Department for Work and Pensions in London.

He was knighted in the Queen’s New Year’s Honours 2010 for services to health and healthcare. In 2016, he was elected to fellowship of the Learned Society of Wales.

Cari-Anne Quinn
Conducting innovation, accelerating adoption and creating transformational partnerships: How Life Sciences Hub Wales will work with industry and the NHS to achieve mutual success.

Cari-Anne Quinn, Interim Chief Executive,  Life Sciences Hub Wales

Cari-Anne Quinn has worked in a wide range of economic development roles with Welsh Government including working overseas with the Welsh Development Agency.  For the last five years, Cari-Anne has led the Welsh Government Life Science Sector Team.  A key part of that role involved the establishment of the Life Sciences Hub Wales where she is now the Interim Chief Executive Officer.

Professor Marc Clement
The Innovation Corridor

Dean of School of Management at Swansea University

Professor Marc Clement graduated with a First Class Honours degree in Physics from Swansea University and a PhD in Laser Physics from Swansea University with the research undertaken at the Rutherford Laborator

Marc then gained a Fellowship from the Royal Society to study at the Centre d'Etudes Nucléaires de Saclay, in Paris. He has held several senior academic positions including being the Vice Chancellor of the University of Wales for six years before returning to become Executive Chair in the Institute of Life Science at the College of Medicine, Swansea University.

In 2014 Marc was invited to become Vice President of Swansea University with a specific role of developing major strategic projects; and more recently in October 2015, Marc was appointed as Dean of the School of Management, Swansea University. Marc has also held a number of public appointments serving on and chairing committees on behalf of Welsh Government and representing Wales on the UK Board of the National Endowment for Science, Technology and the Arts (NESTA).

Marc is an entrepreneur having founded several businesses and is the named inventor of many patents in the field of medical devices, he is also a board member for ARCH (A Regional Collaboration for Health).

Caroline Thompson

CEO - Be The Spark CIC

Caroline Thompson is the newly appointed CEO of Be The Spark CIC. Be The Spark is a movement designed to connect like minded people and to bring together innovation and entrepreneurship. It aims to build a community that will help transform Wales, inspire the next generation and ultimately trigger more start-ups, more innovation & commercialisation, more opportunities and more jobs.

Prior to taking up her position with BeTheSpark, Caroline was the NatWest lead for the Entrepreneurial Spark accelerator hubs in both Bristol & Cardiff. Caroline has over 28 years of experience in banking with NatWest in variety of roles – cross division - ranging from Risk & Regulation to Human Resources, and 12 years of experience in leading teams.

Professor Keith Harding

Professor Keith Harding CBE FRCGP FRCP FRCS FLSW

Professor Keith Harding had a longstanding interest in wound healing. He has undergone training in both general surgery and general practice.  He was appointed as the first Director of the Wound Healing Research Unit in 1991.  From 2011 – 2013 he was Director of TIME Institute (Translation, Innovation, Methodology and Engagement) and Head of Wound Healing Research Unit, School of Medicine, Cardiff University and Clinical Lead for Wound Healing in the Cardiff & Vale NHS Trust.  In September 2013 he was appointed as Dean of Clinical Innovation at Cardiff University and in 2014 was appointed as Medical Director of the Welsh Wound Innovation Centre.  His clinical practice is exclusively focused on treating patients with wound healing problems with a wide range of aetiologies. He holds external professorial appointments at universities in the UK and Australia. He has authored over 350 publications in the field of wound healing and has written a number of chapters and books in this area.  He is the Editor-in-Chief of the International Wound Journal published by Wiley.  He was the First President of the European Pressure Ulcer Advisory Panel, First Recorder of the European Wound Management Association and is a Past President of the European Tissue Repair Society.  He was Chair of the International Working Group on Wound Healing in Diabetic Foot Disease, Chair of the Expert Working Group that produced a range of International Consensus Documents from 2004 – 2011.  Has obtained funding of over £45 million from a range of academic, commercial and clinical sources since the Wound Healing Research Unit was created in 1991.  He was awarded the CBE in the New Year Honours list in January 2013 for Services to Medicine and Health Care.  In 2013 he was awarded £4.2 million to set up the Welsh Wound Innovation Initiative part of which has enabled the setting up of the first Wound Healing Centre in the World.  The centre is designed to coordinate academic activity, both in terms of teaching and research, in addition to providing a coordinated approach to the care of patients with wounds.  In 2014 he was awarded the The Learned Society of Wales Fellowship.

Dr. Steven Klein
Innovation, Partnerships, and Prosperity in Quebec: The IRICoR Model of Transforming Research into Innovative Therapies

Dr. Steven Klein is Vice-President, Business Development at IRICoR, where he brings over 15 years of business development experience in a variety of fields, including oncology, vaccines, and CNS-related indications.   Prior to joining IRICoR, Dr. Klein held Business Development roles at Labopharm, BELLUS Health, Neurochem, the Canadian Network for Vaccines and Immunotherapeutics (CANVAC), and Vasogen.

During his career, Dr. Klein has negotiated and concluded a wide range of licensing and co-development agreements with industry leaders such as Bristol-Myers Squibb, Pfizer, Merck, Roche, GSK, Domain Therapeutics, Encycle Therapeutics, Nippon Shinyaku, Grunenthal, and Sanofi Pasteur.  He has also served as acting CEO of ExCellThera, and played a key role in the creation of SpecificiT, two cell therapy companies recently spun out of IRICoR.

Dr Klein holds a B.Sc. (Honors) in Chemistry from Concordia University, a Ph.D. in Experimental Medicine from McGill University, and an MBA from Queen’s University. Dr. Klein is a Board member of the Centre for the Commercialization of Antibodies and Biologics (Toronto, Canada).

Louis Lillywhite

Louis Lillywhite is a Senior Consulting Fellow at the he Royal Institute of International Affairs (Chatham House) Centre on Global Health Security, leading on issues relating to health and conflict, although he has also being involved in work on infectious disease, and was a member of the post-Ebola WHO Committee which reviewed the role of the International Health Regulations.  He is a medical member of the Tribunal Appeal Service (Wales and South West) which deals with appeals in respect of health-related social security benefits.   He had a 42 year career in the Army, with his last appointment being the Armed Forces Surgeon General, and was for 6 years the Chief Medical Officer for St John Ambulance (England).  Although formally retired from the Army, he has recently been appointed Master-General of the Army Medical Services.   He is a Trustee and Past-President of the Medical Society of London, and a Trustee and patron of a number of other organizations.  He is a Bevan Commissioner. 

Dr. Ian Campbell

Director for Health and Life Sciences

Dr Ian Campbell is an experienced executive in life sciences and the diagnostics sector. In October 2016 Ian took up the post of Director for Health and Life Sciences at Innovate UK. Prior to that, he most recently served as Chief Executive of ArquerDiagnostics, a company developing and commercialising immunoassay tests for cancers of the urinogenitary tract.

Previously he served as Chief Executive of Imperial College spin-out company Molecular Vision, developing a disposable, quantitative point-of-care diagnostic platform, before being acquired by Abingdon Health in 2012. Ian has also served as Commercial Director with BespakEurope. Ian has a strong scientific background, gaining his PhD at the University of Glasgow.

Professor Karol Sikora
Wales leading the future of UK oncology with proton beam therapy.

Professor Karol Sikora, Chief Medical Officer, Proton Partners International.

Proton Partners International is at the vanguard of advancing cancer care, building a series of oncology centres across the UK known as the Rutherford Cancer Centres, with its first centre in Newport, South Wales, the first in the UK to offer high energy proton beam therapy. The Rutherford Cancer Centres are at the forefront of providing innovative cancer care, providing all-encompassing cancer services, offering world-class proton beam therapy, along with traditional services, including diagnostics, chemotherapy, radiotherapy, and holistic therapy. Centres in Northumberland, Reading and Liverpool are also under development. Find out more about proton beam therapy and its application in delivering cancer services from Professor Karol Sikora, Chief Medical Officer of Proton Partners International.

Karol Sikora is Chief Medical Officer of Proton Partners International. He was the founder of Cancer Partners UK which has created UK’s largest independent UK cancer network with private equity. He was Professor and Chairman of the Department of Cancer Medicine at Imperial College School of Medicine and is still honorary Consultant Oncologist at Hammersmith Hospital, London.  He is Dean and Professor of Medicine at Britain’s first independent Medical School at the University of Buckingham and a Fellow of Corpus Christi College, Cambridge. He has published over 300 papers and written or edited 20 books including Treatment of Cancer - the standard British postgraduate textbook, now in its sixth edition. His new book The street-wise patients guide to surviving cancer was published last year.

Dr. Mark Briggs

Mark Briggs is a 20 year veteran of the Life Sciences business within Research and Development with a primary focus upon the development of end-to-end solutions, tools and systems supporting drug discovery, development and safety testing.  Most recently he has been heavily involved in the identification of enabling and disruptive technologies to advance the usability and robustness of production workflows for the industrialisation of cell therapies. 

Currently he is Head of Cell and Gene Therapy for the Welsh Blood Service, leading the development of proposals in this space on behalf of NHS Wales and the Welsh Government.

Cath O'Brien

Cath joined Welsh Blood Service, Velindre NHS Trust as Director in 2013. A Pharmacist by profession, she spent her early career in Cardiff and the South Wales Valleys before moving to senior roles in commercial pharmacy companies, the Royal Pharmaceutical Society and the School of Pharmacy and Pharmaceutical Sciences Cardiff University.  She is currently Deputy Director of the Midlands - Wales Advanced Therapies Treatment Centre (MW-ATTC) and overseeing the development of proposals in this space on behalf of NHS Wales and the Welsh Government.

Mick McGuire

Mick McGuire is the Director for Business and Regions for Welsh Government responsible for growing jobs across all sectors in Wales.  This role has broadened to include Entrepreneurship, Innovation, and Arts and Media.  Previously he was Deputy Director for Financial and Professional Services Sector and for South East Wales Regional Engagement. Mick has 30 years experience in the Financial and Professional Services Sector having worked as MD for Principality Property Company, Director for Sales and Marketing Principality Building Society, Managing Director of Peter Alan Ltd and previously for Royal Insurance (UK) Ltd.

Originally from Belfast, Mick now lives in Penarth and is married with two daughters.  He has an MA in Natural Sciences from Christ’s College Cambridge where he earned a football blue and scored a winning goal at the Varsity match at Wembley. He is an FA coach and a keen golfer.

David Sheppard

David Sheppard, head of China, Europe, Middle East and Africa Department of International Trade Life Science Organisation (LSO)

David Sheppard joined the DIT Life Sciences Organisation in June 2015 and is responsible for leading a team of civil servants and sector specialists to help companies to export life sciences products and services and attract Foreign Direct Investment in his region.

After graduating from Swansea University in History and working for the Gwent-Glamorgan Archaeological Trust, David joined the Ministry of Defence in 1989. Whilst in Defence he worked in equipment procurement, international defence co-operation, the 2001 Armed Forces Parliamentary Act and Human Resources.

From 2008 to 2013 David was Assistant Director for Africa and the Middle East in the UKTI Defence and Security Organisation.  In 2013 he also held the post of Head of Trade and Investment in the British Embassy in Muscat, Oman, where his tour culminated with the signature of a contract worth £2.5 billion to supply 12 Typhoon aircraft to the Royal Air Force of Oman witnessed by the Prime Minister.